{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:16:26Z","timestamp":1777392986009,"version":"3.51.4"},"reference-count":33,"publisher":"SAGE Publications","issue":"s1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2024,8,20]]},"abstract":"<jats:p>Background: The N-glycan structure bisecting N-acetylglucosamine (bisecting GlcNAc) is present on several N-glycans that are elevated in Alzheimer\u2019s disease (AD), and previous studies have shown that bisecting GlcNAc levels correlate with total tau and phospho-tau181 in cerebrospinal fluid at early stages of AD. A recent population-based study showed that bisecting GlcNAc correlates with total tau also in blood and that this correlation could predict conversion to dementia. Objective: In this study, we have further investigated how bisecting GlcNAc relates to total tau and phospho-tau 181 in cerebrospinal fluid samples from controls and cases with early cognitive deficits, stratified by amyloid\/tau status and gender. Methods: Relative levels of bisecting GlcNAc in cerebrospinal fluid were measured by an enzyme-linked lectin assay in individuals with subjective cognitive decline, mild cognitive impairment and controls from the Norwegian Dementia Disease Initiation cohort. Results: As in our previous study, the correlation between bisecting GlcNAc and total tau or phospho-tau181 was particularly strong in the subjective cognitive decline group. The correlation was observed in amyloid negative and tau negative as well as amyloid positive and tau positive individuals, both in females and in males. Interestingly, among the amyloid negative and tau negative individuals, the correlation was observed in individuals with subjective cognitive decline but not in the controls. Conclusions: Thus, bisecting GlcNAc could be a biomarker for early cognitive decline.<\/jats:p>","DOI":"10.3233\/jad-240628","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T12:31:28Z","timestamp":1723206688000},"page":"S93-S101","source":"Crossref","is-referenced-by-count":1,"title":["Bisecting N-Acetylglucosamine Correlates with Phospho-Tau181 in Subjective Cognitive Decline but not in Control Cases"],"prefix":"10.1177","volume":"100","author":[{"given":"Sofia","family":"Egeb\u00e4ck Arulf","sequence":"first","affiliation":[{"name":"Department of Neurobiology, Division of Neurogeriatrics, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin","family":"Ziyue Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Division of Neurogeriatrics, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f8rn-Eivind","family":"Kirsebom","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital of North Norway, Troms\u2013, Norway"},{"name":"Department of Psychology, Faculty of Health Sciences, The Arctic University of Norway, Troms\u2013, Norway"},{"name":"Department of Neurology, Akershus University Hospital, L\u2013renskog, Norway"},{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alenka","family":"Jejcic","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Division of Neurogeriatrics, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tormod","family":"Fladby","sequence":"additional","affiliation":[{"name":"Department of Neurology, Akershus University Hospital, L\u2013renskog, Norway"},{"name":"Institute of Clinical Medicine, University of Oslo, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bengt","family":"Winblad","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Division of Neurogeriatrics, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden"},{"name":"Theme Inflammation and Aging, Karolinska University Hospital, Huddinge, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars","family":"Tjernberg","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Division of Neurogeriatrics, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophia","family":"Schedin-Weiss","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, Division of Neurogeriatrics, Care Sciences and Society, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-240628_ref1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/febs.12590","article-title":"The role of protein glycosylation in Alzheimer disease","volume":"281","author":"Schedin-Weiss","year":"2014","journal-title":"FEBS J"},{"key":"10.3233\/JAD-240628_ref2","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.bbagen.2017.04.012","article-title":"N-glycan and Alzheimer\u2019s disease","volume":"1861","author":"Kizuka","year":"2017","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.3233\/JAD-240628_ref3","doi-asserted-by":"crossref","first-page":"625348","DOI":"10.3389\/fnins.2020.625348","article-title":"Implications of glycosylation in Alzheimer\u2019s disease","volume":"14","author":"Haukedal","year":"2020","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-240628_ref4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3390\/biom11060858","article-title":"What can N-glycomics and N-glycoproteomics of cerebrospinal fluid tell us about Alzheimer disease?","volume":"11","author":"Gaunitz","year":"2021","journal-title":"Biomolecules"},{"key":"10.3233\/JAD-240628_ref5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2017.04.020","article-title":"Altered protein glycosylation predicts Alzheimer\u2019s disease and modulates its pathology in disease model Drosophila","volume":"56","author":"Frenkel-Pinter","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-240628_ref6","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1111\/febs.15197","article-title":"Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment","volume":"287","author":"Schedin-Weiss","year":"2020","journal-title":"FEBS J"},{"key":"10.3233\/JAD-240628_ref7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/jnc.15202","article-title":"The N-glycan profile in cortex and hippocampus is altered in Alzheimer disease","volume":"159","author":"Gaunitz","year":"2021","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-240628_ref8","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.bbagen.2016.03.009","article-title":"Glycoblotting method allows for rapid and efficient glycome profiling of human Alzheimer\u2019s disease brain, serum and cerebrospinal fluid towards potential biomarker discovery","author":"Gizaw","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-240628_ref9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jprot.2015.10.006","article-title":"CSF N-glycoproteomics for early diagnosis in Alzheimer\u2019s disease","volume":"131","author":"Palmigiano","year":"2016","journal-title":"J Proteomics"},{"key":"10.3233\/JAD-240628_ref10","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1021\/acs.jproteome.9b00504","article-title":"N-Glycan profile of cerebrospinal fluids from Alzheimer\u2019s disease patients using liquid chromatography with mass spectrometry","volume":"18","author":"Cho","year":"2019","journal-title":"J Proteome Res"},{"key":"10.3233\/JAD-240628_ref11","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1002\/alz.13024","article-title":"A glycan epitope correlates with tau in serum and predicts progression to Alzheimer\u2019s disease in combination with APOE4 allele status","volume":"19","author":"Zhou","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-240628_ref12","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/alz.12236","article-title":"Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer\u2019s disease diagnosis","volume":"17","author":"Karikari","year":"2021","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-240628_ref13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-023-00605-8","article-title":"Plasma phospho-tau in Alzheimer\u2019s disease: towards diagnostic and therapeutic trial applications","volume":"18","author":"Gonzalez-Ortiz","year":"2023","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-240628_ref14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3233\/JAD-170231","article-title":"Detecting at-risk Alzheimer\u2019s disease cases","volume":"60","author":"Fladby","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-240628_ref15","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jalz.2014.01.001","article-title":"A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer\u2019s disease","volume":"10","author":"Jessen","year":"2014","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-240628_ref16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-240628_ref17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/13854046.2019.1574902","article-title":"Demographically adjusted CERAD wordlist test norms in a Norwegian sample from 40 to 80 years","volume":"33","author":"Kirsebom","year":"2019","journal-title":"Clin Neuropsychol"},{"key":"10.3233\/JAD-240628_ref18","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/13854046.2020.1829068","article-title":"Demographically adjusted trail making test norms in a Scandinavian sample from 41 to 84 years","volume":"34","author":"Espenes","year":"2020","journal-title":"Clin Neuropsychol"},{"key":"10.3233\/JAD-240628_ref19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/23279095.2021.1918128","article-title":"Regression-based norms for the FAS phonemic fluency test for ages 40-84 based on a Norwegian sample","volume":"30","author":"Lorentzen","year":"2023","journal-title":"Appl Neuropsychol Adult"},{"key":"10.3233\/JAD-240628_ref20","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1037\/neu0000698","article-title":"Predictive and diagnostic utility of brief neuropsychological assessment in detecting Alzheimer\u2019s pathology and progression to dementia","volume":"34","author":"Eliassen","year":"2020","journal-title":"Neuropsychology"},{"key":"10.3233\/JAD-240628_ref21","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s12974-023-02973-w","article-title":"Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer\u2019s disease","volume":"20","author":"Nordengen","year":"2023","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.3233\/JAD-240628_ref22","doi-asserted-by":"crossref","first-page":"20375","DOI":"10.1038\/s41598-021-99794-9","article-title":"Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression","volume":"11","author":"Siafarikas","year":"2021","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-240628_ref23","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jalz.2019.01.015","article-title":"Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer\u2019s disease continuum in the BIOMARKAPD study","volume":"15","author":"Lleo","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-240628_ref24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/glycob\/cwp152","article-title":"Protective effect of N-glycan bisecting GlcNAc residues on beta-amyloid production in Alzheimer\u2019s disease","volume":"20","author":"Akasaka-Manya","year":"2010","journal-title":"Glycobiology"},{"key":"10.3233\/JAD-240628_ref25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/BJ20150607","article-title":"Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions","volume":"473","author":"Kizuka","year":"2016","journal-title":"Biochem J"},{"key":"10.3233\/JAD-240628_ref26","doi-asserted-by":"crossref","first-page":"175","DOI":"10.15252\/emmm.201404438","article-title":"An aberrant sugar modification of BACE1 blocks its lysosomal targeting in Alzheimer\u2019s disease","volume":"7","author":"Kizuka","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-240628_ref27","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm0896-871","article-title":"Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer\u2019s disease","volume":"2","author":"Wang","year":"1996","journal-title":"Nat Med"},{"key":"10.3233\/JAD-240628_ref28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0014-5793(01)02421-8","article-title":"Analysis of N-glycans of pathological tau: possible occurrence of aberrant processing of tau in Alzheimer\u2019s disease","volume":"496","author":"Sato","year":"2001","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-240628_ref29","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0306-4522(02)00510-9","article-title":"Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5","volume":"115","author":"Liu","year":"2002","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-240628_ref30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0014-5793(02)02228-7","article-title":"Role of glycosylation in hyperphosphorylation of tau in Alzheimer\u2019s disease","volume":"512","author":"Liu","year":"2002","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-240628_ref31","doi-asserted-by":"crossref","first-page":"109863","DOI":"10.1016\/j.neuropharm.2024.109863","article-title":"DHEC mesylate attenuates pathologies and aberrant bisecting N-glycosylation in Alzheimer\u2019s disease models","volume":"248","author":"Wang","year":"2024","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-240628_ref32","doi-asserted-by":"crossref","first-page":"107133","DOI":"10.1016\/j.phrs.2024.107133","article-title":"Targeting aberrant glycosylation to modulate microglial response and improve cognition in models of Alzheimer\u2019s disease","volume":"202","author":"Wang","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.3233\/JAD-240628_ref33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00018-020-03578-9","article-title":"Neural glycomics: the sweet side of nervous system functions","volume":"78","author":"Sytnyk","year":"2021","journal-title":"Cell Mol Life Sci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-240628","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:58:47Z","timestamp":1777370327000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-240628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,20]]},"references-count":33,"journal-issue":{"issue":"s1"},"URL":"https:\/\/doi.org\/10.3233\/jad-240628","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,20]]}}}